Clinical Value of Early Serum Albumin in Predicting Mortality Among Patients With Acute Pancreatitis: A Meta-Analysis

Read full text Summarise with VIRAT
Authors: M. Helali, S. Mustafa, Mohamed Elhadi Mohamed Elbashir, Khalid Elwalid Ahmed Ali, Abubakr Ali M Humidan, Ammar Mohamed Ibrahim Obeidalla, Mohamed Mamoun Abbas Khalafalla, Bishoy Alfred William Dawis, Mohamed Shamseldin Mustafa Khalid, Alaa Kamal Hassan Hamedelnile, Mona Waheeb Khalifa Rahamt Alla, Mohamed Fatahelalim Ayed
+4 more Ahmad Mufid Kanaan, Maaz Mohamed Sharfeldin Nasreldin, Maher Abdallah Atieh Yousef, Dafaalla Salih
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Acute pancreatitis (AP) is a critical illness that carries a considerable risk of severe complications and mortality. Serum albumin has been suggested as a marker of severity and worse outcomes in various critical illnesses. Accordingly, this meta-analysis was done to determine the clinical value of serum albumin in predicting mortality in patients with AP. A systematic review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The search was performed in PubMed, Scopus, and the WHO Virtual Health Library (VHL) to retrieve relevant studies assessing the association between serum albumin and mortality in patients with AP. Statistical analyses were done by calculating the pooled standardized mean difference (SMD) and area under the curve (AUC) estimates with 95% CI, using the meta package of R version 4.4.3 (R Foundation for Statistical Computing, Vienna, Austria). A total of 16 studies, including 8,394 patients, were included in the meta-analysis. The results indicated that non-survivors had significantly lower serum albumin levels than survivors (SMD = -0.79; 95% CI -1.11 to -0.47; p < 0.0001). Prognostic accuracy analysis demonstrated moderate discriminatory ability for serum albumin (AUC = 0.75; 95% CI 0.67 to 0.82; p < 0.001). This meta-analysis demonstrates that hypoalbuminemia is an important biomarker for identifying patients with AP who are at increased risk of mortality.

Fields of Study & Subjects

Pancreatitis Pathology and Treatment Sepsis Diagnosis and Treatment Acute Kidney Injury Research

Publication details

Journal / source
Cureus
Volume
18
Issue
3
Pages
e105664–e105664
Publication date
22 March 2026
Language
EN